Ledger.Open graph →
SEC Form D · filed September 10, 2024

Strella Biotechnology, Inc

Offering
$5.6M
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Seattle, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Katherine Sizov · Philadelphia, PAExec · DirectorEric Linn · Seattle, WADirectorNolan Paul · Seattle, WADirectorKatherine Sizov · Philadelphia, PAExec · DirectorEric Linn · Seattle, WADirectorNolan Paul · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗